1. Home
  2. HLX vs MLYS Comparison

HLX vs MLYS Comparison

Compare HLX & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLX
  • MLYS
  • Stock Information
  • Founded
  • HLX 1979
  • MLYS 2019
  • Country
  • HLX United States
  • MLYS United States
  • Employees
  • HLX N/A
  • MLYS N/A
  • Industry
  • HLX Oilfield Services/Equipment
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLX Energy
  • MLYS Health Care
  • Exchange
  • HLX Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • HLX 959.2M
  • MLYS 890.6M
  • IPO Year
  • HLX 1997
  • MLYS 2023
  • Fundamental
  • Price
  • HLX $5.72
  • MLYS $14.52
  • Analyst Decision
  • HLX Buy
  • MLYS Strong Buy
  • Analyst Count
  • HLX 3
  • MLYS 4
  • Target Price
  • HLX $12.00
  • MLYS $27.00
  • AVG Volume (30 Days)
  • HLX 2.0M
  • MLYS 785.9K
  • Earning Date
  • HLX 07-23-2025
  • MLYS 08-12-2025
  • Dividend Yield
  • HLX N/A
  • MLYS N/A
  • EPS Growth
  • HLX N/A
  • MLYS N/A
  • EPS
  • HLX 0.33
  • MLYS N/A
  • Revenue
  • HLX $1,277,904,000.00
  • MLYS N/A
  • Revenue This Year
  • HLX N/A
  • MLYS N/A
  • Revenue Next Year
  • HLX $7.34
  • MLYS N/A
  • P/E Ratio
  • HLX $17.49
  • MLYS N/A
  • Revenue Growth
  • HLX N/A
  • MLYS N/A
  • 52 Week Low
  • HLX $5.52
  • MLYS $8.24
  • 52 Week High
  • HLX $12.33
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • HLX 39.98
  • MLYS 57.42
  • Support Level
  • HLX $5.58
  • MLYS $12.59
  • Resistance Level
  • HLX $6.09
  • MLYS $13.70
  • Average True Range (ATR)
  • HLX 0.26
  • MLYS 0.75
  • MACD
  • HLX -0.02
  • MLYS 0.11
  • Stochastic Oscillator
  • HLX 15.34
  • MLYS 75.39

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: